138 related articles for article (PubMed ID: 15888259)
1. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis.
Totaro R; Passacantando A; Russo T; Parzanese I; Rascente M; Marini C; Tonietti G; Carolei A
Int J Immunopathol Pharmacol; 2005; 18(2):377-83. PubMed ID: 15888259
[TBL] [Abstract][Full Text] [Related]
2. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
4. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients.
Ersoy E; Kuş CN; Sener U; Coker I; Zorlu Y
Eur J Neurol; 2005 Mar; 12(3):208-11. PubMed ID: 15693810
[TBL] [Abstract][Full Text] [Related]
5. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Smith DR; Balashov KE; Hafler DA; Khoury SJ; Weiner HL
Ann Neurol; 1997 Sep; 42(3):313-8. PubMed ID: 9307252
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b.
Markovic-Plese S; Bielekova B; Kadom N; Leist TP; Martin R; Frank JA; McFarland HF
Neurology; 2003 Jun; 60(11):1849-51. PubMed ID: 12796549
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
Trenova AG; Manova MG; Kostadinova II; Murdjeva MA; Hristova DR; Vasileva TV; Zahariev ZI
Folia Med (Plovdiv); 2011; 53(2):29-35. PubMed ID: 21797104
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
[TBL] [Abstract][Full Text] [Related]
9. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
10. Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS.
Gayo A; Mozo L; Suárez A; Tuñón A; Lahoz C; Gutiérrez C
Neurology; 1999 Jun; 52(9):1764-70. PubMed ID: 10371521
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
[TBL] [Abstract][Full Text] [Related]
12. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
[TBL] [Abstract][Full Text] [Related]
13. Assessing multiple sclerosis activity: is the in vitro production of tumor necrosis factor-alpha, interleukins 2, 6, 4, and 10, and immunoglobulin G of value?
Schluep M; van Melle G; Henry H; Städler C; Roth-Wicky B; Magistretti PJ
J Neurol; 1999 Nov; 246(11):1041-50. PubMed ID: 10631636
[TBL] [Abstract][Full Text] [Related]
14. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Comabella M; Balashov K; Issazadeh S; Smith D; Weiner HL; Khoury SJ
J Clin Invest; 1998 Aug; 102(4):671-8. PubMed ID: 9710434
[TBL] [Abstract][Full Text] [Related]
15. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients.
Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
Eur J Neurol; 2000 Nov; 7(6):647-53. PubMed ID: 11136350
[TBL] [Abstract][Full Text] [Related]
16. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab.
Barbero P; Bergui M; Versino E; Ricci A; Zhong JJ; Ferrero B; Clerico M; Pipieri A; Verdun E; Giordano L; Durelli L;
Mult Scler; 2006 Feb; 12(1):72-6. PubMed ID: 16459722
[TBL] [Abstract][Full Text] [Related]
17. Effects of interferon β-1a and interferon β-1b monotherapies on selected serum cytokines and nitrite levels in patients with relapsing-remitting multiple sclerosis: a 3-year longitudinal study.
Stępień A; Chalimoniuk M; Lubina-Dąbrowska N; Chrapusta SJ; Galbo H; Langfort J
Neuroimmunomodulation; 2013; 20(4):213-22. PubMed ID: 23711618
[TBL] [Abstract][Full Text] [Related]
18. A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
Smith DR; Weinstock-Guttman B; Cohen JA; Wei X; Gutmann C; Bakshi R; Olek M; Stone L; Greenberg S; Stuart D; Orav J; Stuart W; Weiner H
Mult Scler; 2005 Oct; 11(5):573-82. PubMed ID: 16193896
[TBL] [Abstract][Full Text] [Related]
19. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA
Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
